Helle‐Mai Loit

14.8k total citations
16 papers, 365 citations indexed

About

Helle‐Mai Loit is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, Helle‐Mai Loit has authored 16 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Physiology. Recurrent topics in Helle‐Mai Loit's work include HIV, Drug Use, Sexual Risk (5 papers), Obesity, Physical Activity, Diet (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Helle‐Mai Loit is often cited by papers focused on HIV, Drug Use, Sexual Risk (5 papers), Obesity, Physical Activity, Diet (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Helle‐Mai Loit collaborates with scholars based in Estonia, Sweden and United States. Helle‐Mai Loit's co-authors include Jaanus Harro, Idoia Labayen, Toomas Veidebaum, Michael Sjöstróm, Jonatan R. Ruiz, Francisco B. Ortega, Anneli Uusküla, Kristi Rüütel, Liis Merenäkk and Eva Rönmark and has published in prestigious journals such as Diabetes Care, Medicine & Science in Sports & Exercise and Psychopharmacology.

In The Last Decade

Helle‐Mai Loit

16 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helle‐Mai Loit Estonia 11 138 121 62 61 53 16 365
Maarit Valtonen Finland 13 131 0.9× 124 1.0× 34 0.5× 51 0.8× 30 0.6× 54 462
Jane Blood‐Siegfried United States 11 51 0.4× 80 0.7× 104 1.7× 45 0.7× 10 0.2× 29 496
Kesley Pablo Morais de Azevedo Brazil 11 49 0.4× 99 0.8× 27 0.4× 16 0.3× 10 0.2× 27 359
Sandrijn van Schaik United States 10 135 1.0× 110 0.9× 18 0.3× 122 2.0× 16 0.3× 29 442
Stéphanie Giezendanner Switzerland 13 46 0.3× 69 0.6× 29 0.5× 45 0.7× 4 0.1× 52 465
Tom Powell United Kingdom 10 31 0.2× 75 0.6× 33 0.5× 141 2.3× 5 0.1× 43 360
Nazgol Motamed-Gorji Iran 12 73 0.5× 118 1.0× 46 0.7× 40 0.7× 22 0.4× 23 387
Liz Cook United Kingdom 10 80 0.6× 135 1.1× 134 2.2× 12 0.2× 10 0.2× 30 552
Conrad J. Clemens United States 10 61 0.4× 68 0.6× 39 0.6× 93 1.5× 22 0.4× 23 558
G Gillett New Zealand 12 25 0.2× 111 0.9× 48 0.8× 11 0.2× 11 0.2× 42 392

Countries citing papers authored by Helle‐Mai Loit

Since Specialization
Citations

This map shows the geographic impact of Helle‐Mai Loit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helle‐Mai Loit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helle‐Mai Loit more than expected).

Fields of papers citing papers by Helle‐Mai Loit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helle‐Mai Loit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helle‐Mai Loit. The network helps show where Helle‐Mai Loit may publish in the future.

Co-authorship network of co-authors of Helle‐Mai Loit

This figure shows the co-authorship network connecting the top 25 collaborators of Helle‐Mai Loit. A scholar is included among the top collaborators of Helle‐Mai Loit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helle‐Mai Loit. Helle‐Mai Loit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Eensoo, Diva, Marika Paaver, Mariliis Vaht, Helle‐Mai Loit, & Jaanus Harro. (2018). Risky driving and the persistent effect of a randomized intervention focusing on impulsivity: The role of the serotonin transporter promoter polymorphism. Accident Analysis & Prevention. 113. 19–24. 17 indexed citations
2.
Rüütel, Kristi, Ave Talu, Katri Abel‐Ollo, et al.. (2013). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy. 25(1). 175–178. 5 indexed citations
3.
Rüütel, Kristi, David R. Parker, Igor S. Sobolev, & Helle‐Mai Loit. (2012). Tuberculosis Knowledge among Injecting Drug Users Visiting Syringe Exchange Program in Tallinn, Estonia. Central European Journal of Public Health. 20(4). 248–251. 1 indexed citations
4.
Tomson, Katrin, Liis Merenäkk, Helle‐Mai Loit, Jarek Mäestu, & Jaanus Harro. (2011). The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(8). 1857–1862. 39 indexed citations
5.
Ortega, Francisco B., Idoia Labayen, Jonatan R. Ruiz, et al.. (2011). Improvements in Fitness Reduce the Risk of Becoming Overweight across Puberty. Medicine & Science in Sports & Exercise. 43(10). 1891–1897. 73 indexed citations
6.
Rüütel, Kristi, et al.. (2011). Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Research Notes. 4(1). 192–192. 8 indexed citations
7.
Martínez‐Vizcaíno, Vicente, Francisco B. Ortega, Montserrat Solera-Martínez, et al.. (2011). Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovascular Diabetology. 10(1). 81–81. 22 indexed citations
8.
Merenäkk, Liis, Jarek Mäestu, Niklas Nordquist, et al.. (2010). Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study. Psychopharmacology. 215(1). 13–22. 25 indexed citations
9.
Labayen, Idoia, Jonatan R. Ruiz, Francisco B. Ortega, et al.. (2010). Intergenerational Cardiovascular Disease Risk Factors Involve Both Maternal and Paternal BMI. Diabetes Care. 33(4). 894–900. 52 indexed citations
10.
Rüütel, Kristi, Heti Pisarev, Helle‐Mai Loit, & Anneli Uusküla. (2009). Factors influencing quality of life of people living with HIV in Estonia: a cross‐sectional survey. Journal of the International AIDS Society. 12(1). 13–13. 34 indexed citations
11.
Rüütel, Kristi, et al.. (2008). Quality of Life of People Living with HIV and AIDS in Estonia. Central European Journal of Public Health. 16(3). 111–115. 6 indexed citations
12.
Loit, Helle‐Mai, et al.. (2006). Allergic Sensitization to Common Airborne Allergens among Adults in Estonia. International Archives of Allergy and Immunology. 142(3). 247–254. 19 indexed citations
13.
Loit, Helle‐Mai, et al.. (2005). Low Prevalence of Asthma in Westernizing Countries—Myth or Reality? Prevalence of Asthma in Estonia—A Report from the “FinEsS” Study. Journal of Asthma. 42(5). 357–365. 11 indexed citations
14.
Rönmark, Eva, et al.. (2005). Correct Use of Three Powder Inhalers: Comparison Between Diskus, Turbuhaler, and Easyhaler. Journal of Asthma. 42(3). 173–178. 14 indexed citations
15.
Rönmark, Eva, et al.. (2005). Correct Use of Three Powder Inhalers: Comparison Between Diskus, Turbuhaler, and Easyhaler. Journal of Asthma. 42(3). 173–178. 37 indexed citations
16.
Loit, Helle‐Mai, et al.. (2005). Low Prevalence of Asthma in Westernizing Countries - Myth or Reality? Prevalence of Asthma in Estonia - A Report from the "FinEsS" Study. Journal of Asthma. 42(5). 357–365. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026